Racial/Ethnic and Socioeconomic Disparities in Use of Direct-Acting Antivirals Among Medicare Beneficiaries with Chronic Hepatitis C, 2014-2016

BACKGROUND: New hepatitis C virus (HCV) drugs—direct-acting antivirals (DAAs)—are highly effective but costly, which raises a concern about limited access to DAAs by vulnerable populations. Previous studies of disparities in DAA use across patient groups showed mixed results, but their generalizabil...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Manag Care Spec Pharm
Main Authors: Jung, Jeah, Du, Ping, Feldman, Roger, Kong, Lan, Riley, Thomas
Formato: Artigo
Idioma:Inglês
Publicado em: Academy of Managed Care Pharmacy 2019
Assuntos:
Research Brief
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6823635/
https://ncbi.nlm.nih.gov/pubmed/31663464
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18553/jmcp.2019.25.11.1236
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados